Stem cell biology and drug discovery.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Stem cell therapy as a promising approach for ischemic stroke treatment.Current research in pharmacology and drug discovery · 2024
   Review
2. Induced pluripotent stem cell technology in bone biology.Bone · 2023
   Article
3. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.Molecules (Basel, Switzerland) · 2022
   Article
4. Editorial: Directing Stem Cell Fate Using Plant Extracts and Their Bioactive Compounds.Frontiers in cell and developmental biology · 2022
   Article
5. Regulating Early Biological Events in Human Amniotic Epithelial Stem Cells Using Natural Bioactive Compounds: Extendable Multidirectional Research Avenues.Frontiers in cell and developmental biology · 2022
   Article
6. DNA Microarray-Based Global Gene Expression Profiling in Human Amniotic Epithelial Cells Predicts the Potential of Microalgae-Derived Squalene for the Nervous System and Metabolic Health.Biomedicines · 2021
   Article
7. Stem Cell-Based Therapies: What Interventional Radiologists Need to Know.Seminars in interventional radiology · 2021
   Review
8. A New Chapter for Mesenchymal Stem Cells: Decellularized Extracellular Matrices.Stem cell reviews and reports · 2017
   Review
9. Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.Annual review of pharmacology and toxicology · 2016
   Review
10. iPSC technology--Powerful hand for disease modeling and therapeutic screen.BMB reports · 2015
    Review
11. How multi-organ microdevices can help foster drug development.Advanced drug delivery reviews · 2014
    Review
12. In-silico models of stem cell and developmental systems.Theoretical biology & medical modelling · 2014
    Review
13. Phenotypic assays for β-amyloid in mouse embryonic stem cell-derived neurons.Chemistry & biology · 2013
    Article
14. Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells.Acta pharmacologica Sinica · 2013
    Review
15. Overview of micro- and nano-technology tools for stem cell applications: micropatterned and microelectronic devices.Sensors (Basel, Switzerland) · 2012
    Review
16. A high-throughput screen for Wnt/β-catenin signaling pathway modulators in human iPSC-derived neural progenitors.Journal of biomolecular screening · 2012
    Article
17. Revisiting lab-on-a-chip technology for drug discovery.Nature reviews. Drug discovery · 2012
    Review
18. Integration of Molecular, Cellular and Translational Researches in BioImpacts.BioImpacts : BI · 2011
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as